Korian announces Laurent Lemaire as Group CFO alongside the new CEO Sophie Boissard

– FRANCE, Paris – Korian (Paris:KORI), European leader of Ageing Well, announces Laurent Lemaire’s appointment as Group Chief Financial Officer. As such, he joins the Group Executive Committee.

With , new Chief Executive Officer of Korian, who will take up her position on 26 January 2016, Laurent LEMAIRE will pilot, at Group level, the Finance, Legal and Tax, Purchases, and IT departments. He will notably manage the financial performance and the growth of the Group.

Graduated from ESSEC, Laurent LEMAIRE was previously Chief Financial Officer of SOPRA STERIA Group. He began his career in 1989 within DANONE where he held various positions within the Finances department, among which those of Director of Investor Relations and Financial communication (1999-2002), Financial Director of Danone Eaux France (2002-2005) and Financial Director of the Worldwide Beverages Division (2005-2007). In 2007, he joins the executive management of STERIA as Managing Director Finances, Legal, Purchases, IT and Transformation. Since the creation of SOPRA STERIA Group, he was Chief Financial Officer of the new group.

Laurent LEMAIRE will take up his position at the latest on the 1st of March 2016.

ABOUT KORIAN

Korian, Europe’s leading Ageing Well specialist, founded in 2003, has the capacity to accommodate some 70,000 residents and patients in Europe (France, Germany, Italy and Belgium) and employs around 45,000 people. The Group manages almost 700 facilities in four business lines: nursing homes, post-acute and rehabilitation clinics, assisted living facilities and home-care services.

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

here the original post =>